DiagNodus (United Kingdom)

BackgroundFaecal tests are widely applied for colorectal cancer (CRC) screening and considered for triaging symptomatic patients with suspected CRC. However, faecal tests can be inconvenient, complex and expensive. Colorectal mucus (CM) sampled using our new patient-friendly non-invasive technique is rich in CRC biomarkers. This study aimed to evaluate diagnostic accuracy of CRC detection by measuring protein biomarkers in CM.MethodsColorectal mucus samples were provided by 35 healthy controls, 62 CRC-free symptomatic patients and 40 CRC patients. Biomarkers were quantified by ELISA. Diagnostic performances of haemoglobin, C-reactive protein, tissue inhibitor of metalloproteinases-1, M2-pyruvate kinase, matrix metalloproteinase-9, peptidyl arginine deiminase-4, epidermal growth factor receptor, calprotectin and eosinophil-derived neurotoxin were assessed using receiver operating characteristic (ROC) curve analysis.ResultsColorectal mucus haemoglobin was superior compared to other biomarkers. For haemoglobin, the areas under the curve for discriminating between CRC and healthy groups (‘screening’) and between CRC and symptomatic patients (‘triage’) were 0.921 and 0.854 respectively. The sensitivity of 80.0% and specificities of 94.3% and 85.5% for the two settings respectively were obtained.ConclusionsHaemoglobin quantification in CM reliably detects CRC. This patient-friendly approach presents an attractive alternative to faecal immunochemical test; however, the two methods need to be directly compared in larger studies.

Global increase of human longevity results in the emergence of previously ignored ageing-related problems. Skin ageing is a well-known phenomenon, but active search for scientific approaches to its prevention and even skin rejuvenation is a relatively new area. Although the structure and composition of the stratum corneum (SC), the superficial layer of epidermis, is well studied, relatively little is known about the residual skin surface components (RSSC) that overlay the surface of the SC. The aim of this study was to examine morphological features of RSSC samples non-invasively collected from the surface of human facial skin for the presence of age-related changes. Residual skin surface component samples were collected by swabbing from the surface of facial skin of 60 adult male volunteers allocated in two age groups: 34 subjects aged in the range 18-32 years and 26 subjects aged in the range 58-72 years. The collected samples were analysed microscopically: the size of the lipid droplets was measured; desquamated corneocytes and lipid crystals were counted; and microbial presence was assessed semi-quantitatively. Age-related changes were revealed for all studied components of the RSSC. There was a significant (P = 0.0126) decrease in the size of lipid droplets among older men. Likewise, significantly (P = 0.0252) lower numbers of lipid crystals were present in this group. In contrast, microbial presence in the RSSC was significantly (P = 0.0019) increased in the older group. There was also a trend towards more abundant corneocyte desquamation among older men, but the difference has not reached statistical significance (P = 0.0636). Non-invasively collected RSSC samples present an informative material for studying age-related changes on the surface of the SC of human facial skin. The results of this study confirm earlier observations regarding age-associated decline of the efficiency of the epidermal barrier and can be used for testing new approaches to skin ageing prevention.

Non-invasive diagnosis of colorectal disease remains problematic, fecal biomarkers presenting the only current option. Colorectal mucus is the diagnostically informative element of stool samples, but its separation from stool is difficult. We aimed to: (i) test a novel method of non-invasive colorectal mucus sampling in a pilot clinical trial; (ii) evaluate sampling method acceptance by study participants; (iii) characterize the collected material cytologically; and (iv) assess feasibility of quantitative protein analysis in the samples. A total of 141 patients with IBD (58), IBS (50), and healthy controls (33) participated in the study. Samples rich in colorectal mucus were self-collected by swabbing the anal area immediately following defecation. Collected samples were examined cytologically and subjected to quantitative analysis for total protein and mucin 2 (MUC2). The novel sampling technique was assessed as "good" or "adequate" by 96% of study participants. A total of 55% of the collected samples were free of fecal contamination. Cytology showed large numbers of well preserved inflammatory cells in IBD cases. Total protein values varied in all groups, being affected by fecal contamination. MUC2 levels were similar among all IBD-free individuals (control and IBS groups) and elevated in IBD patients (p < 0.001). MUC2 measurement applied as a test for IBD detection provided sensitivity = 72.4% and specificity = 86.7%. A novel non-invasive method for collecting human colorectal mucus has been successfully tested. The method was very well accepted by trial participants. The results have proven high quality of collected samples for both cytological investigation and diagnostic biomarker analysis.